Sativex in the United States

Sativex, the liquid form of marijuana being marketed by GW Pharmaceuticals, has been given the OK by the Food and Drug Administration to skip ahead to phase III trials in the U.S. — actual testing on advanced stage cancer patients to last 24 to 36 months.
I guess GW gets the preferred treatment. They don’t have to buy their marijuana from the U.S. government. They get to use their own.
Interesting.